Chinese drugmaker stocks fall on possible US clampdown

Trump reportedly considering new curbs on imports of experimental pharmaceuticals

20250911 china pharma

The U.S. is threatening China's pharmaceuticals boom with possible import restrictions and policies to promote domestic production. © Reuters

LORRETTA CHEN

HONG KONG -- Stocks of major Chinese pharmaceutical companies tumbled Thursday due to concerns that the U.S. is considering major restrictions on the sector, which has taken off in recent years.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.